Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 12;59(8):1456.
doi: 10.3390/medicina59081456.

Robot-Assisted Parathyroidectomy Using Indocyanine Green (ICG) Fluorescence in Primary Hyperparathyroidism

Affiliations

Robot-Assisted Parathyroidectomy Using Indocyanine Green (ICG) Fluorescence in Primary Hyperparathyroidism

Shin-Young Park et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Surgical treatment for primary hyperparathyroidism (PHPT) has evolved from bilateral exploration through a long transcervical incision to focused parathyroidectomy with a minimal incision above the pathologic gland. Recently, endoscopic or robot-assisted parathyroid surgery without direct neck incision has been introduced. The aim of this study was to investigate the effectiveness of indocyanine green (ICG) fluorescence as a new method for the visual identification of abnormal hyperfunctioning parathyroid glands in robot-assisted parathyroidectomy using FireflyTM technology. We also aimed to conduct a comparative analysis between robot-assisted parathyroidectomy and conventional focused parathyroidectomy in order to identify clinical differences between the two surgical approaches. Materials and Methods: A total of 37 patients with PHPT underwent parathyroidectomy at a single university hospital between September 2018 and December 2022. Thirty-one patients underwent open focused parathyroidectomy (open group), and six patients underwent robot-assisted parathyroidectomy (robot group). Pre-operative localization via parathyroid SPECT-CT and an intraoperative parathyroid hormone (IOPTH) assay were used to successfully remove the pathologic parathyroid in both groups. ICG was administered only in the robot group. Results: Pathologic parathyroid showed a persistent fluorescence pattern under near-infrared vision. After the removal of the fluorescent parathyroid gland, IOPTH was normalized in all six patients in the robot group. However, the open group showed shorter hospital stays (1.8 ± 1.2 vs. 3.0 ± 0.0 days, p < 0.001) and shorter operation times (91.1 ± 69.1 vs. 152.5 ± 23.6 min, p = 0.001) than the robot group. After 6 months of surgery, PTH, calcium, and ionized calcium levels were all normalized without significant differences between the groups. Conclusions: Robot-assisted parathyroidectomy using ICG is helpful for the visual identification of the pathologic parathyroid gland. The advantage of robot parathyroidectomy is a better cosmetic outcome. However, it still does not show better clinical outcomes than conventional open focused parathyroidectomy.

Keywords: indocyanine green fluorescence; primary hyperparathyroidism; robotic parathyroidectomy.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any conflict of interest.

Figures

Figure 1
Figure 1
Parathyroid view in robot BABA parathyroidectomy. (A) Right parathyroid under natural vision; (B) ICG fluorescence imaging of the right parathyroid under NIR; (C) left parathyroid under natural vision; (D) ICG fluorescence imaging of the left parathyroid under NIR. The white arrows indicate the parathyroid glands, and the yellow arrows indicate the lymph nodes. The parathyroid gland exhibited fluorescence under NIR light, whereas the lymph node did not, allowing for differentiation between them despite their similar appearance.
Figure 2
Figure 2
Postoperative scar after parathyroidectomy. (A) Focused parathyroidectomy made a minimal incision size of 2.5 to 3 cm on the neck; (B) a near absence of visible scarring can be observed in robot BABA parathyroidectomy.

References

    1. Sociedade Brasileira de Endocrinologia e Metabolismo. Bandeira F., Griz L., Chaves N., Carvalho N.C., Borges L.M., Lazaretti-Castro M., Borba V., Castro L.C., Borges J.L., et al. Diagnosis and management of primary hyperparathyroidism—A scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq. Bras. Endocrinol. Metabol. 2013;57:406–424. doi: 10.1590/S0004-27302013000600002. - DOI - PubMed
    1. Yu N., Donnan P.T., Murphy M.J., Leese G.P. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin. Endocrinol. 2009;71:485–493. doi: 10.1111/j.1365-2265.2008.03520.x. - DOI - PubMed
    1. Gasser R.W. Clinical aspects of primary hyperparathyroidism: Clinical manifestations, diagnosis, and therapy. Wien Med. Wochenschr. 2013;163:397–402. doi: 10.1007/s10354-013-0235-z. - DOI - PubMed
    1. Yeh M.W., Ituarte P.H., Zhou H.C., Nishimoto S., Liu I.L., Harari A., Haigh P.I., Adams A.L. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 2013;98:1122–1129. doi: 10.1210/jc.2012-4022. - DOI - PMC - PubMed
    1. Abood A., Vestergaard P. Increasing incidence of primary hyperparathyroidism in Denmark. Dan Med. J. 2013;60:A4567. - PubMed

LinkOut - more resources